JENNIFER BEDNARZ: Open Payments
NPI 1306498571 · DES PLAINES, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,098 in 107 payments from 43 companies in 2025. Trend: 2023 $1,838 · 2024 $2,491 · 2025 $3,098
Food & beverage: $2,784Education: $314
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 13 | $371 |
| ABBVIE INC. | 13 | $249 |
| ADC THERAPEUTICS AMERICA, INC. | 3 | $156 |
| Celgene Corporation | 5 | $155 |
| Lilly USA, LLC | 2 | $148 |
| AstraZeneca Pharmaceuticals LP | 7 | $141 |
| Janssen Biotech, Inc. | 5 | $130 |
| SOBI, INC | 2 | $122 |
| Merck Sharp & Dohme LLC | 4 | $118 |
| Astellas Pharma US Inc | 4 | $109 |
Products named: REBLOZYL, ZYNLONTA, EPKINLY, KISQALI, VENCLEXTA, FUROSCIX, Doptelet, BRUKINSA.
Industry payments across IL — which companies pay providers there.
